drugset / Trial / NCT05799157
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase 2 study has been designed to determine the safety and efficacy of repeated treatment sessions of VDMN-21 patch at two dose strengths as compared to a matched vehicle control patch in subjects with verruca vulgaris
Timeline
- Start
- 2023-02-28
- Primary completion
- 2025-02-25
- Completion
- 2025-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VDMN-21 | Unknown | 125 ug | Topical |
| Subject | VDMN-21 | Unknown | 250 ug | Topical |